Evaluation of PSMA-Targeted TREN-CAM Conjugates for Targeted Imaging of Cancer with <sup>68</sup>Ga(III) and <sup>45</sup>Ti(IV)

Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup>, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2-</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup>, and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> form readily at room temperature within 15 min with a molar activity of 24-29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2-</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup> and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup> complex is observed when compared with that of [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> is excreted >98% intact, while [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup> exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup> isotopes.

Authors

Institutions

Publication Details

Journal
Bioconjugate Chemistry
Published
2025-03-19
DOI
https://doi.org/10.1021/acs.bioconjchem.5c00099
Citations
1
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
1.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of PSMA-Targeted TREN-CAM Conjugates for Targeted Imaging of Cancer with 68Ga(III) and 45Ti(IV)

Angus J. Koller, Martin Dierolf, Molly C. DeLuca, Valérie C. Pierre et al.
1 citations
Bioconjugate Chemistry
Radiopharmaceutical Chemistry and Applications
1.36
article

Evaluation of PSMA-Targeted TREN-CAM Conjugates for Targeted Imaging of Cancer with 68Ga(III) and 45Ti(IV)

Angus J. Koller, Martin Dierolf, Molly C. DeLuca, Valérie C. Pierre, Eduardo Alucio-Sarduy, Axia Marlin, Eszter Boros, Dariusz Śmiłowicz, Phuong Tran, Jonathan W. Engle, Owen M. Glaser, M. Andrey Joaqui Joaqui, Mallory J. Gork
article en
1 citations

Abstract

Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup>, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2-</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup>, and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> form readily at room temperature within 15 min with a molar activity of 24-29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2-</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup> and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup> complex is observed when compared with that of [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3-</sup> is excreted >98% intact, while [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2-</sup> exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup> isotopes.

Bioconjugate ChemistryVol. 36(4)
University of Wisconsin–Madison (US), University of Utah (US), Stony Brook University (US)
U.S. Department of Energy, National Institute of Biomedical Imaging and Bioengineering, Division of Chemistry
Good health and well-being
Openalex Percentile: Top 22%
Radiopharmaceutical Chemistry and Applications
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.